<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00402740</url>
  </required_header>
  <id_info>
    <org_study_id>640-0071</org_study_id>
    <nct_id>NCT00402740</nct_id>
  </id_info>
  <brief_title>Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)</brief_title>
  <acronym>PROTECT</acronym>
  <official_title>Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Vascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Vascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the long-term safety and efficacy of the Xact™ Rapid
      Exchange Carotid Stent System used in conjunction with the Emboshield® Pro Rapid Exchange
      Embolic Protection System (Generation 5) and the Emboshield® BareWire™ Rapid Exchange Embolic
      Protection System (Generation 3), in the treatment of atherosclerotic carotid artery disease
      in high-surgical risk subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Kaplan-Meier Estimate of Freedom From the Composite of Any Death, Stroke and MI During the 30 Day Post Procedural Period (DSMI), Plus Fatal and Non-fatal Ipsilateral Stroke From 31-365 Days and Annually Thereafter for a Total of 3 Years.</measure>
    <time_frame>3 years</time_frame>
    <description>Freedom from DSMI to 30 days or ipsilateral stroke from 31 days to 3 years. KM event free (%) curve.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute Device Success</measure>
    <time_frame>Post-procedure</time_frame>
    <description>Defined by the attainment of &lt;50% residual stenosis covering an area no longer than the original lesion treated with the stent.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>30 Days</time_frame>
    <description>Defined as the attainment of less than 50% residual stenosis (per angiographic core lab) of the target lesion and the absence of DSMI at 30 days post-index procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of Any Transient Ischemic Attack (TIA) and Amaurosis Fugax</measure>
    <time_frame>≤30 days</time_frame>
    <description>Includes only each subject's first occurrence of each event.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kapan-Meier Estimate of Freedom From Clinically Driven Target Lesion Revascularization Through Three Years.</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">322</enrollment>
  <condition>Carotid Artery Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Xact Stent with either Emboshield Pro (Gen 5) or Emboshield (Gen 3)</intervention_name>
    <description>All subjects will receive the Xact™ Rapid Exchange Carotid Stent System. The first 220 consecutively enrolled subjects will be treated with the investigational filter system, the Emboshield® Pro Rapid Exchange Embolic Protection System (Generation 5). The remaining subjects will be treated with the FDA approved Emboshield® BareWire™ Rapid Exchange Embolic Protection System (Generation 3).</description>
    <other_name>Xact stent</other_name>
    <other_name>Emboshield Pro (Gen 5)</other_name>
    <other_name>Emboshield (Gen 3)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria Subject must be ≥ 18 years of age.

        Subject has the ability to cooperate with study procedures and agrees to return for all
        required follow-up visits, tests and exams.

        Female subjects of childbearing potential must have a documented negative pregnancy test
        within 30 days prior to the index procedure.

        Subjects taking warfarin may be included if their dosage is reduced before the index
        procedure to result in an INR of 1.5 or less. Warfarin may be restarted to therapeutic dose
        after the index procedure.

        The subject must sign a written informed consent prior to the initiation of any study
        procedures, using a form that is approved by the Institutional Review Board (IRB) or
        Medical Ethics Committee (EC).

        The life expectancy of the subject is at least two years.

        The subject has a lesion located in the internal carotid artery (ICA); the carotid
        bifurcation may be involved.

        The target lesion is intended to be treated with a single stent.

        Target ICA vessel diameter must be visually estimated to be:

          -  ≥2.5 mm and ≤7.0 for the Emboshield Pro (Gen 5)

          -  ≥ 2.8 mm and ≤6.2 for the Emboshield (Gen 3)

        And

          -  ≥4.0 mm and ≤9.0 mm for the Xact Stent treatment area.

        The subject has a carotid artery stenosis determined by ultrasound or angiography (visual
        estimate) to be:

          -  ≥50% for symptomatic subjects

        Or

          -  ≥80% for asymptomatic subjects

        High-risk inclusion criteria for either anatomical or co-morbid risk factors are present.
        The subject must fulfill at least one of the criteria, Category I or II risk factors,
        listed below to meet the inclusion criteria.

        Category I Anatomic Risk Factors

          -  Previous radiation treatment to the neck or radical neck dissection

          -  Target lesion is at or above the second vertebral body C2 (level of jaw)

          -  Inability to extend the head due to cervical arthritis or other cervical disorders

          -  Tracheostomy or tracheal stoma

          -  Laryngectomy

          -  Contralateral laryngeal nerve palsy

          -  Severe tandem lesions

        Category II Co-morbid Risk Factors

          -  Previous CEA with significant restenosis (as defined for symptomatic or asymptomatic
             subjects)

          -  Total occlusion of the contralateral carotid artery

          -  Left ventricular ejection fraction &lt; 35%

          -  Congestive Heart failure New York Heart Association (NYHA) Functional Class III or
             higher

          -  Dialysis dependent renal failure

          -  Canadian Cardiovascular Society Angina Classification III or higher or unstable angina

          -  Requires coronary artery bypass surgery, cardiac valve surgery, peripheral vascular
             surgery, or abdominal aortic aneurysm repair within 60 days

             •≥80 years of age

          -  Myocardial infarction within previous 6 weeks

          -  Abnormal stress test. Treadmill, thallium or dobutamine echo are acceptable. The
             stress tests should be sufficiently abnormal to place the subject at increased risk
             for CEA. This includes subjects with two or more proximal diseased coronary arteries
             of &gt;70% stenosis that have not or cannot be revascularized or &lt;30 days since
             revascularization.

          -  Severe pulmonary disease, including at least one of the following: requires chronic O2
             therapy; resting PO2 ≤60 mm Hg, Hematocrit ≥50%, FEV₁ or DLCO ≤50% of normal.

        Exclusion Criteria

          -  The subject is participating in another investigational trial that would interfere
             with the conduct or result of this study.

          -  The subject has dementia or a neurological illness that may confound the neurological
             evaluation.

          -  Total occlusion of the target vessel.

          -  There is an existing, previously placed stent in the target artery.

          -  The subject has a known life-threatening allergy to the contrast media that cannot be
             treated.

          -  Subject has history of intolerance or allergic reaction to any of the study
             medications including aspirin, Clopidogrel bisulfate (Plavix®) or Ticlopidine
             (Ticlid®), heparin or Bivalirudin (Angiomax™). Subjects must be able to tolerate a
             combination of aspirin and Clopidogrel or aspirin and Ticlopidine.

          -  The subject has a GI bleed that would interfere with antiplatelet therapy.

          -  The subject has known cardiac sources of emboli, including but not limited to current
             or past history of paroxysmal or sustained atrial fibrillation (treated or untreated),
             valve replacement, etc.

          -  Subject has Hemoglobin (Hgb) less than 8 gm/dL (unless on dialysis), platelet count
             &lt;50,000/mm3, or known heparin associated thrombocytopenia.

          -  The subject has a history of bleeding diathesis or coagulopathy including
             thrombocytopenia or an inability to receive heparin or Bivalirudin (Angiomax™) in
             amounts sufficient to maintain an ACT of &gt;250, or will refuse blood transfusion.

          -  The subject has atherosclerotic disease involving adjoining vessels that precludes
             safe placement of the guiding catheter or sheath.

          -  The subject has other abnormal angiographic findings that indicate the subject is at
             risk for a stroke due to a problem other than that of the target lesion, such as:
             ipsilateral arterial stenosis greater in severity than the target lesion, cerebral
             aneurysm, or arteriovenous malformation of the cerebral vasculature.

          -  There is evidence of a carotid artery dissection prior to the initiation of the index
             procedure.

          -  There is an angiographically visible thrombus.

          -  There is any condition that precludes proper angiographic assessment, placement of the
             cerebral protective system or makes percutaneous arterial access unsafe, e.g. morbid
             obesity, sustained systolic blood pressure &gt;180 mm Hg, tortuosity, occlusive disease,
             vessel anatomy, or aortic arch anatomy.

          -  Occlusion (TIMI 0 flow), or string sign of the ipsilateral common or internal carotid
             artery.

          -  There is evidence of bilateral carotid stenosis that would require intervention within
             30 days of the index procedure.

          -  There is evidence of a stroke within the previous 30 days of the index procedure.

          -  There is a planned treatment of a non-target lesion within 30 days post-index
             procedure.

          -  There is a history of intracranial hemorrhage within the previous 3 months, including
             hemorrhagic transformation of an ischemic stroke.

          -  There is a history of an ipsilateral stroke with fluctuating neurologic symptoms
             within one year of the index procedure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seemant Chaturvedi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Wayne State University Stroke Program</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William A Gray, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jon Matsumura, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington Hospital</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <zip>94538</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>El Camino Hospital</name>
      <address>
        <city>Mountain View</city>
        <state>California</state>
        <zip>94040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hoag Memorial Hospital Presbyterian</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Connecticut Health Center</name>
      <address>
        <city>Farmington</city>
        <state>Connecticut</state>
        <zip>06030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Hospital Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lakeland Regional Medical Center</name>
      <address>
        <city>Lakeland</city>
        <state>Florida</state>
        <zip>33805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Munroe Regional Medical Center</name>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <zip>34475</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hawaii Permanente Medical Group-Kaiser Foundation Hospital</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96819</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. John's Hospital / Memorial Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parkview Hospital</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Hospital and Health Care Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Terrebonne General Medical Center</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington Adventist Hospital</name>
      <address>
        <city>Takoma Park</city>
        <state>Maryland</state>
        <zip>20912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph Mercy Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McLaren Regional Medical Center</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48532</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Genesys Regional Medical Center</name>
      <address>
        <city>Grand Blanc</city>
        <state>Michigan</state>
        <zip>48439</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Our Lady of Lourdes Medical Center</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Michael's Medical Center</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Millard Fillmore Hospital-Kaleida Health Systems</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lenox Hill Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>WakeMed Hospital</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Hospital</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pinnacle Health Hospital</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Medical center</name>
      <address>
        <city>Wyomissing</city>
        <state>Pennsylvania</state>
        <zip>19610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Memorial Medical Center</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Holston Valley Medical Center</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Medical Center West / Baptist Hospital of East Tennessee</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37934</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Heart P.A.</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Presbyterian Heart Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Episcopal Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chesapeake General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bon Secours St. Mary's Hospital</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Medical Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/22236885</url>
    <description>Results of carotid artery stenting with distal embolic protection with improved systems: Protected Carotid Artery Stenting in Patients at High Risk for Carotid Endarterectomy (PROTECT) trial.</description>
  </link>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2006</study_first_submitted>
  <study_first_submitted_qc>November 21, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2006</study_first_posted>
  <results_first_submitted>May 7, 2012</results_first_submitted>
  <results_first_submitted_qc>May 17, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 20, 2012</results_first_posted>
  <last_update_submitted>May 17, 2012</last_update_submitted>
  <last_update_submitted_qc>May 17, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 20, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Carotid</keyword>
  <keyword>Artery</keyword>
  <keyword>Disease</keyword>
  <keyword>Stent</keyword>
  <keyword>PROTECT</keyword>
  <keyword>XACT</keyword>
  <keyword>EMBOSHIELD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Artery Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A total of 322 subjects were enrolled in the PROTECT study at 38 clinical sites in the United States. The first subject was enrolled on November 29, 2006, and enrollment was completed on June 18, 2008.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Group 1</title>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="322"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="242"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="80"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>No stent. Completed FU at 30 days.</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject disposition unknown.</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group 1</title>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="322"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="251"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72.7" spread="9.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="207"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="322"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Kaplan-Meier Estimate of Freedom From the Composite of Any Death, Stroke and MI During the 30 Day Post Procedural Period (DSMI), Plus Fatal and Non-fatal Ipsilateral Stroke From 31-365 Days and Annually Thereafter for a Total of 3 Years.</title>
        <description>Freedom from DSMI to 30 days or ipsilateral stroke from 31 days to 3 years. KM event free (%) curve.</description>
        <time_frame>3 years</time_frame>
        <population>Intent to Treat (ITT)</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>Includes only the most serious event for each subject and includes only each subject's first occurrence of the event.</description>
          </group>
        </group_list>
        <measure>
          <title>Kaplan-Meier Estimate of Freedom From the Composite of Any Death, Stroke and MI During the 30 Day Post Procedural Period (DSMI), Plus Fatal and Non-fatal Ipsilateral Stroke From 31-365 Days and Annually Thereafter for a Total of 3 Years.</title>
          <description>Freedom from DSMI to 30 days or ipsilateral stroke from 31 days to 3 years. KM event free (%) curve.</description>
          <population>Intent to Treat (ITT)</population>
          <units>Event-free percentage</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="322"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.5" lower_limit="1.72" upper_limit="6.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Acute Device Success</title>
        <description>Defined by the attainment of &lt;50% residual stenosis covering an area no longer than the original lesion treated with the stent.</description>
        <time_frame>Post-procedure</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Xact Stent</title>
            <description>The Xact stent success were counted per subject</description>
          </group>
          <group group_id="O2">
            <title>Emboshield Pro Gen 5</title>
            <description>Participants receiving Emboshield Pro Gen 5. Emboshield Pro success were counted per filter.</description>
          </group>
          <group group_id="O3">
            <title>Emboshield Gen 3</title>
            <description>Participants receiving Emboshield Gen 3 Emboshield Gen3 success were counted per filter.</description>
          </group>
        </group_list>
        <measure>
          <title>Acute Device Success</title>
          <description>Defined by the attainment of &lt;50% residual stenosis covering an area no longer than the original lesion treated with the stent.</description>
          <population>ITT</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="317"/>
                <count group_id="O2" value="222"/>
                <count group_id="O3" value="101"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.7" lower_limit="96.80" upper_limit="99.66"/>
                    <measurement group_id="O2" value="97.3" lower_limit="94.21" upper_limit="99.00"/>
                    <measurement group_id="O3" value="97.0" lower_limit="91.56" upper_limit="99.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Success</title>
        <description>Defined as the attainment of less than 50% residual stenosis (per angiographic core lab) of the target lesion and the absence of DSMI at 30 days post-index procedure.</description>
        <time_frame>30 Days</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
          </group>
        </group_list>
        <measure>
          <title>Procedural Success</title>
          <description>Defined as the attainment of less than 50% residual stenosis (per angiographic core lab) of the target lesion and the absence of DSMI at 30 days post-index procedure.</description>
          <population>ITT</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="322"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.30" lower_limit="92.43" upper_limit="97.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite of Any Transient Ischemic Attack (TIA) and Amaurosis Fugax</title>
        <description>Includes only each subject's first occurrence of each event.</description>
        <time_frame>≤30 days</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
          </group>
        </group_list>
        <measure>
          <title>Composite of Any Transient Ischemic Attack (TIA) and Amaurosis Fugax</title>
          <description>Includes only each subject's first occurrence of each event.</description>
          <population>ITT</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="322"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" lower_limit="1.29" upper_limit="5.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Kapan-Meier Estimate of Freedom From Clinically Driven Target Lesion Revascularization Through Three Years.</title>
        <time_frame>3 years</time_frame>
        <population>ITT</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
          </group>
        </group_list>
        <measure>
          <title>Kapan-Meier Estimate of Freedom From Clinically Driven Target Lesion Revascularization Through Three Years.</title>
          <population>ITT</population>
          <units>Event-free percentage</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="317"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Three years post-procedure</time_frame>
      <desc>Organ systems designations were chosen to match Abbott Categories coding as closely as possible and may differ from other coding systems.</desc>
      <group_list>
        <group group_id="E1">
          <title>Group 1</title>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>Abbott Categories</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="221" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <description>Blood dyscrasia</description>
                <counts group_id="E1" events="27" subjects_affected="27" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <description>Blood dyscrasia</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal lab test</sub_title>
                <description>Cardiac</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Angina</sub_title>
                <description>Cardiac</description>
                <counts group_id="E1" events="15" subjects_affected="10" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <description>Cardiac</description>
                <counts group_id="E1" events="46" subjects_affected="30" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <description>Cardiac</description>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Congestive heart failure</sub_title>
                <description>Cardiac</description>
                <counts group_id="E1" events="41" subjects_affected="30" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Coronary artery diseasee</sub_title>
                <description>Cardiac</description>
                <counts group_id="E1" events="51" subjects_affected="39" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Hypertensive cardiovascular disease</sub_title>
                <description>Cardiac</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Myocardial infarctionsee</sub_title>
                <description>Cardiac</description>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Structural heart disease</sub_title>
                <description>Cardiac</description>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <description>Hemodynamic</description>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Myocardial infarction Non Q wave</sub_title>
                <description>Myocardial infarction</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <description>?Procedure related? or neurological?</description>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <description>Procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal</sub_title>
                <description>Bleeding</description>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Gastrointestinal</sub_title>
                <description>Other</description>
                <counts group_id="E1" events="50" subjects_affected="32" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Presyncope /syncope</sub_title>
                <description>Hemodynamic</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <description>Hemodynamic</description>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <description>?Procedure related?</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Allergic reaction</sub_title>
                <description>Other</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Miscellaneous</sub_title>
                <description>Other</description>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <description>Other</description>
                <counts group_id="E1" events="33" subjects_affected="26" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Hematoma</sub_title>
                <description>Access site complication</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Occlusion</sub_title>
                <description>Access site complication</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <description>Bleeding</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Dissection</sub_title>
                <description>Procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <description>Procedure related</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <description>Procedural</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <description>Procedure related</description>
                <counts group_id="E1" events="26" subjects_affected="26" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <description>Procedure related?</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Dissection</sub_title>
                <description>Vascular</description>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Instent restenosis</sub_title>
                <description>Vascular</description>
                <counts group_id="E1" events="9" subjects_affected="7" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Metabolic</sub_title>
                <description>Other</description>
                <counts group_id="E1" events="18" subjects_affected="14" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Musculoskeletal</sub_title>
                <description>Other</description>
                <counts group_id="E1" events="33" subjects_affected="29" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Cancer</sub_title>
                <description>Other</description>
                <counts group_id="E1" events="32" subjects_affected="26" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amaurosis fugax</sub_title>
                <description>Neurologic other than stroke</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Confusion</sub_title>
                <description>Neurologic other than stroke</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Hyperperfusion syndrome</sub_title>
                <description>Neurologic other than stroke</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Neurologic other</sub_title>
                <description>Neurologic other than stroke
??I'll require a little more information.</description>
                <counts group_id="E1" events="26" subjects_affected="21" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <description>Neurologic other than stroke</description>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Transient Ischemic Attack</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Visual disturbance</sub_title>
                <description>?? or eye disorders ??</description>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Ipsilateral major</sub_title>
                <description>Stroke</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Ipsilateral minor</sub_title>
                <description>Stroke</description>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Mental health related</sub_title>
                <description>Other</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Trauma</sub_title>
                <description>Other</description>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <description>Hemodynamic</description>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Genitourinarynal</sub_title>
                <description>Other</description>
                <counts group_id="E1" events="34" subjects_affected="26" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory</sub_title>
                <description>Other</description>
                <counts group_id="E1" events="91" subjects_affected="55" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Subdural hematoma</sub_title>
                <description>Neurologic other than stroke</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Epistaxis</sub_title>
                <description>Bleeding</description>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Hematuria</sub_title>
                <description>Bleeding</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Oropharyngeal</sub_title>
                <description>Bleeding</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aneurysm</sub_title>
                <description>Vascular</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <description>Vascular</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disease</sub_title>
                <description>Vascular</description>
                <counts group_id="E1" events="30" subjects_affected="23" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Pseudoaneurysm</sub_title>
                <description>Vascular</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Restenosis</sub_title>
                <description>Vascular</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Stenosis</sub_title>
                <description>Vascular</description>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <description>Vascular</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Non-ipsilateral major</sub_title>
                <description>Stroke</description>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Non-ipsilateral minor</sub_title>
                <description>Stroke</description>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5.0</frequency_threshold>
        <default_vocab>Abbott Categories</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="236" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" events="23" subjects_affected="20" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="27" subjects_affected="25" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <description>Procedure related</description>
                <counts group_id="E1" events="24" subjects_affected="22" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <description>Procedure related</description>
                <counts group_id="E1" events="45" subjects_affected="43" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Other: Gastrointestinal</sub_title>
                <counts group_id="E1" events="98" subjects_affected="48" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <description>Procedure related</description>
                <counts group_id="E1" events="18" subjects_affected="17" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Nausea/vomiting</sub_title>
                <description>Procedure related</description>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Other: Genitourinary</sub_title>
                <counts group_id="E1" events="63" subjects_affected="43" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Other: Metabolic</sub_title>
                <counts group_id="E1" events="36" subjects_affected="28" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Other: Miscellaneous</sub_title>
                <description>?? i'll need additional description</description>
                <counts group_id="E1" events="118" subjects_affected="63" subjects_at_risk="313"/>
              </event>
              <event>
                <sub_title>Other: Trauma</sub_title>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Other: Infection</sub_title>
                <counts group_id="E1" events="52" subjects_affected="31" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Pain</sub_title>
                <description>Procedure related</description>
                <counts group_id="E1" events="36" subjects_affected="30" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Other: Musculoskeletal</sub_title>
                <counts group_id="E1" events="122" subjects_affected="67" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Neurologic other</sub_title>
                <description>??Neurologic other than stroke?? I may need additional description</description>
                <counts group_id="E1" events="51" subjects_affected="37" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Other: Respiratory</sub_title>
                <counts group_id="E1" events="80" subjects_affected="55" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Peripheral vascular disease</sub_title>
                <description>Procedure related</description>
                <counts group_id="E1" events="34" subjects_affected="28" subjects_at_risk="313"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Principal Investigator (PI), Institute, and Research Site (RS) acknowledge this is a multi-center study. An independent, joint publication is anticipated from investigators in the study, including the PI. Therefore, the PI, Institute, and RS agree not to publish or present the results before the publication of the multi-center investigator paper, but in no event shall PI, Institute, and/or RS be so restricted after the expiration of twelve months from completion of the Study at all sites.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ellen Travis, MS, NFP</name_or_title>
      <organization>Abbott Vascular</organization>
      <phone>408 845-1512</phone>
      <email>Ellen.Travis@av.abbott.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

